HALIX BV
Pre-clinicalHALIX, licensed end-to-end biologics CDMO for the development & GMP manufacturing of viral vectors and recombinant proteins at clinical & commercial scale
Founded
2012
Focus
BiologicsVaccines
About
HALIX, licensed end-to-end biologics CDMO for the development & GMP manufacturing of viral vectors and recombinant proteins at clinical & commercial scale
Funding History
2Total raised: $20.5M
Debt$12MRegional development bankJun 15, 2022
Grant$8.5MEuropean CommissionOct 15, 2020
Company Info
TypePrivate
Founded2012
LocationLeiden, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile